Cargando…
Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study
PURPOSE: Telomere attrition and corresponding cellular senescence of the retinal pigment epithelium contribute to the changes of age-related macular degeneration. Activation of the enzyme telomerase can add telomeric DNA to retinal pigment epithelium chromosomal ends and has been proposed as a treat...
Autores principales: | Dow, Coad Thomas, Harley, Calvin B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734847/ https://www.ncbi.nlm.nih.gov/pubmed/26869760 http://dx.doi.org/10.2147/OPTH.S100042 |
Ejemplares similares
-
Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023) -
Functional Outcomes of the Low Vision Depression Prevention Trial in Age-Related Macular Degeneration
por: Deemer, Ashley D., et al.
Publicado: (2017) -
Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration? A Prospective, Randomized, Pilot Study
por: Solomon, Sharon D, et al.
Publicado: (2021) -
Update on Clinical Trials in Dry Age-related Macular Degeneration
por: Taskintuna, Ibrahim, et al.
Publicado: (2016) -
Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial
por: Russo, Andrea, et al.
Publicado: (2018)